Evidence map›Paper›PMID 38551577›Full record

ArticleAngewandte Chemie (International ed. in English)2024

Final Stages in the Biosynthesis of the [FeFe]-Hydrogenase Active Site.

Xin Yu, Guodong Rao, R David Britt, Thomas B Rauchfuss

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Biosynthesis of the Selenium-Substituted [FeFe]-Hydrogenases.Journal of the American Chemical Society · 2026
    Article
  3. Article
  4. [FeInorganic chemistry · 2025
    Article
  5. In vitro maturation of fully active [FeFe]-hydrogenase in a defined system including the iron carrier NfuA.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  6. Article
  7. Frequency and time domainPhysical chemistry chemical physics : PCCP · 2025
    Article
  8. Synthesis of [FeOrganometallics · 2025
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xin YuSchool of Chemical Sciences, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.
Guodong RaoDepartment of Chemistry, University of California, Davis, CA 95616, USA.
R David BrittDepartment of Chemistry, University of California, Davis, CA 95616, USA.
Thomas B RauchfussSchool of Chemical Sciences, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.ORCID 0000-0003-2547-5128

Funding

FE-S ENSEMBLES RELATED TO HYDROGENASE ACTIVITYR01GM061153 · NIGMS · UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN · PI RAUCHFUSS, THOMAS · 2000 to 2025
$6.7M
Supplement:Spectroscopy Investigations of Metalloenzyme MechanismsR35GM126961 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI R. David Britt · 2018 to 2026
$3.7M
NIGMS NIH HHS R01 GM061153NIGMS NIH HHS R35 GM126961NIH HHS 1R35GM126961-01NIH HHS GM61153
6 · The paper itself

Abstract

The paper aims to elucidate the final stages in the biosynthesis of the [2Fe]

Indexed as

Catalytic DomainHydrogenaseIron-Sulfur ProteinsMolecular StructureHydrogenaseiron hydrogenaseIron-Sulfur Proteinsbiosynthesiscofactorelectron-nuclear double resonance (ENDOR) spectroscopyhydrogenaseiron

Identifiers

PMID38551577
PMCPMC11253240

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.